Abstract
Rapid advances in liver surgery, including liver transplantation, radiology, and pathology, have created a need for clinically relevant nomenclature for premalignant and early lesions of hepatocellular carcinoma (HCC). Precancerous lesions include dysplastic foci and dysplastic nodules (DNs) characterized by cytologic or structural atypia. Although imaging diagnosis is playing a crucial role in the evaluation of hepatocarcinogenesis and early diagnosis of HCC, it is still challenging to accurately characterize borderline nodules such as small arterially enhancing lesions or hypovascular nodules. This article discusses pathological and radiological features of these small nodular lesions and offers insights into the multistep process of hepatocarcinogenesis by describing the progression of pathologic change linking DNs to HCC.
Similar content being viewed by others
References
Anonymous (1995) Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 22:983–993
International Consensus Group for Hepatocellular Neoplasia (2008) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658–664
Theise ND, Curado MP, Franceschi S, et al. (2010) Hepatocellular carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system. Lyon: International agency of research on cancer, pp 205–216
Lim JH, Kim EY, Lee WJ, et al. (1999) Regenerative nodules in liver cirrhosis: findings at CT during arterial portography and CT hepatic arteriography with histopathologic correlation. Radiology 210:451–458
Krinsky GA, Lee VS (2000) MR imaging of cirrhotic nodules. Abdom Imaging 25:471–482
Kim T, Baron RL, Nalesnik MA (2000) Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. AJR Am J Roentgenol 175:1121–1125
Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 210:443–450
Kim E, Choi D, Lim HK, Lim JH (2004) Multiple infarcted regenerative nodules in liver cirrhosis after systemic hypotension due to septic shock: radiologic findings. Abdom Imaging 29:208–210
Mitchell DG, Rubin R, Siegelman ES, Burk DL Jr, Rifkin MD (1991) Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 178:101–103
Terada T, Kadoya M, Nakanuma Y, Matsui O (1990) Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver. Histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies. Cancer 65:1994–2000
Ito K, Mitchell DG, Gabata T, et al. (1999) Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Radiology 212:235–240
Krinsky GA, Lee VS, Nguyen MT, et al. (2001) Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology 218:47–53
Krinsky GA, Lee VS, Nguyen MT, et al. (2000) Siderotic nodules at MR imaging: regenerative or dysplastic? J Comput Assist Tomogr 24:773–776
Terada T, Nakanuma Y (1989) Survey of iron-accumulative macroregenerative nodules in cirrhotic livers. Hepatology 10:851–854
Watanabe S, Okita K, Harada T, et al. (1983) Morphologic studies of the liver cell dysplasia. Cancer 51:2197–2205
Borzio M, Bruno S, Roncalli M, et al. (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 108:812–817
Le Bail B, Bernard PH, Carles J, Balabaud C, Bioulac-Sage P (1997) Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol 27:835–842
Plentz RR, Park YN, Lechel A, et al. (2007) Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 45:968–976
Kim H, Oh BK, Roncalli M, et al. (2009) Large liver cell change in hepatitis B virus-related liver cirrhosis. Hepatology 50:752–762
Anthony PP, Vogel CL, Barker LF (1973) Liver cell dysplasia: a premalignant condition. J Clin Pathol 26:217–223
Libbrecht L, Craninx M, Nevens F, Desmet V, Roskams T (2001) Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 39:66–73
Ganne-Carrie N, Chastang C, Chapel F, et al. (1996) Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 23:1112–1118
Koo JS, Kim H, Park BK, et al. (2008) Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B. J Clin Gastroenterol 42:738–743
Park YN, Roncalli M (2006) Large liver cell dysplasia: a controversial entity. J Hepatol 45:734–743
Hytiroglou P, Park YN, Krinsky G, Theise ND (2007) Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am 36:867–887 (vii)
Park YN, Yang CP, Fernandez GJ, et al. (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662
Roncalli M, Roz E, Coggi G, et al. (1999) The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 30:1174–1178
Park YN, Kim YB, Yang KM, Park C (2000) Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med 124:1061–1065
Kondo F, Ebara M, Sugiura N, et al. (1990) Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality. Hepatology 12:592–598
Seki S, Sakaguchi H, Kitada T, et al. (2000) Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. Clin Cancer Res 6:3469–3473
Kobayashi M, Ikeda K, Hosaka T, et al. (2006) Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer 106:636–647
Terasaki S, Kaneko S, Kobayashi K, Nonomura A, Nakanuma Y (1998) Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 115:1216–1222
Theise ND, Park YN, Kojiro M (2002) Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 6:497–512
Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172–178
Theise ND, Schwartz M, Miller C, Thung SN (1992) Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology 16:949–955
Kojiro M, Roskams T (2005) Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 25:133–142
Kondo Y, Kanai Y, Sakamoto M, et al. (2000) Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 32:970–979
Maggioni M, Coggi G, Cassani B, et al. (2000) Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies. Hepatology 32:942–946
Sun M, Eshleman JR, Ferrell LD, et al. (2001) An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36–p34 region. Hepatology 33:1415–1424
Tornillo L, Carafa V, Sauter G, et al. (2002) Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest 82:547–553
Choi BI, Han JK, Hong SH, et al. (1999) Dysplastic nodules of the liver: imaging findings. Abdom Imaging 24:250–257
Hayashi M, Matsui O, Ueda K, et al. (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172:969–976
Honda H, Tajima T, Kajiyama K, et al. (1999) Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings. AJR Am J Roentgenol 173:1213–1217
Lim JH, Cho JM, Kim EY, Park CK (2000) Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 214:869–874
Ueda K, Terada T, Nakanuma Y, Matsui O (1992) Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Hum Pathol 23:619–626
Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M (2000) Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 33:282–289
Lim JH, Choi BI (2002) Dysplastic nodules in liver cirrhosis: imaging. Abdom Imaging 27:117–128
Caturelli E, Pompili M, Bartolucci F, et al. (2001) Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Radiology 220:337–342
Kim CK, Lim JH, Lee WJ (2001) Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med 20:99–104
Bennett GL, Krinsky GA, Abitbol RJ, et al. (2002) Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 179:75–80
Baron RL, Peterson M (2001) From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. Radiographics 21:S117–S132
Earls JP, Theise ND, Weinreb JC, et al. (1996) Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201:207–214
Martin J, Puig J, Darnell A, Donoso L (2002) Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis. Semin Ultrasound CT MR 23:62–78
Imai Y, Murakami T, Yoshida S, et al. (2000) Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32:205–212
Lim JH, Choi D, Cho SK, et al. (2001) Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220:669–676
Yoon MA, Kim SH, Park HS, et al. (2009) Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis. Invest Radiol 44:311–321
Kim JI, Lee JM, Choi JY, et al. (2008) The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol 43:202–210
Nakashima O, Sugihara S, Kage M, Kojiro M (1995) Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins. Hepatology 22:101–105
Park YN, Kojiro M, Di Tommaso L, et al. (2007) Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 109:915–923
Kondo F, Kondo Y, Nagato Y, Tomizawa M, Wada K (1994) Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views. J Gastroenterol Hepatol 9:604–612
Di Tommaso L, Franchi G, Park YN, et al. (2007) Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 45:725–734
Di Tommaso L, Destro A, Seok JY, et al. (2009) The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol 50:746–754
Abdul-Al HM, Makhlouf HR, Wang G, Goodman ZD (2008) Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma. Hum Pathol 39:209–212
Desmet VJ (2009) East-west pathology agreement on precancerous liver lesions and early hepatocellular carcinoma. Hepatology 49:355–357
Muramatsu Y, Nawano S, Takayasu K, et al. (1991) Early hepatocellular carcinoma: MR imaging. Radiology 181:209–213
Takayasu K, Furukawa H, Wakao F, et al. (1995) CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. AJR Am J Roentgenol 164:885–890
Lee J, Lee WJ, Lim HK, et al. (2008) Early hepatocellular carcinoma: three-phase helical CT features of 16 patients. Korean J Radiol 9:325–332
Ahn SS, Kim MJ, Lim JS, et al. (2010) Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 255:459–466
Kojiro M (2007) Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West. Hepatol Res 37(Suppl 2):S121–S124
Honda H, Kaneko K, Maeda T, et al. (1997) Small hepatocellular carcinoma on magnetic resonance imaging. Relation of signal intensity to angiographic and clinicopathologic findings. Invest Radiol 32:161–168
Shinmura R, Matsui O, Kobayashi S, et al. (2005) Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply. Radiology 237:512–519
Makuuchi M, Kokudo N, Arii S, et al. (2008) Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 38:37–51
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430
Kudo M, Okanoue T (2007) Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 72(1):2–15
Forner A, Vilana R, Ayuso C, et al. (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97–104
Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34
Sangiovanni A, Manini MA, Iavarone M et al. (2009) The diagnostic and economic impact of contrast imaging technique in the diagnosis of small hepatocellular carcinoma in cirrhosis Gut
Nathan H, Schulick RD, Choti MA, Pawlik TM (2009) Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 249:799–805
Jang HJ, Kim TK, Wilson SR (2009) Small nodules (1–2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound. Eur J Radiol 72:418–424
Kim YK, Lee YH, Kim CS, Han YM (2008) Added diagnostic value of T2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomas. Eur J Radiol 67:304–310
Kondo H, Kanematsu M, Itoh K, et al. (2005) Does T2-weighted MR imaging improve preoperative detection of malignant hepatic tumors? Observer performance study in 49 surgically proven cases. Magn Reson Imaging 23:89–95
Hecht EM, Holland AE, Israel GM, et al. (2006) Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 239:438–447
Hussain HK, Syed I, Nghiem HV, et al. (2004) T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 230:637–644
Acknowlegment
This study was supported by National Research Foundation grant funded by the Korea government (MEST) (No. R13-2002-054-03004-0) (to YN Park).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, Y.N., Kim, MJ. Hepatocarcinogenesis: imaging-pathologic correlation. Abdom Imaging 36, 232–243 (2011). https://doi.org/10.1007/s00261-011-9688-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-011-9688-y